News
11-07-2022, 05:30 PM
A new treatment developed at Tel Aviv University may significantly enhance the efficacy of chemotherapy in breast cancer patients, reducing the risk for lung metastasis following chemo from 52% to only 6%.
More... (https://www.news-medical.net/news/20221107/Combining-chemotherapy-with-an-inflammation-inhibitor-can-prevent-breast-cancer-metastasis.aspx)
More... (https://www.news-medical.net/news/20221107/Combining-chemotherapy-with-an-inflammation-inhibitor-can-prevent-breast-cancer-metastasis.aspx)